Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 8, 2021

Primary Completion Date

July 30, 2025

Study Completion Date

September 10, 2025

Conditions
Severe Symptomatic Aortic Stenosis
Interventions
DEVICE

coronary physiology

To evaluate the association between microvascular disfunction and myocardial fibrosis identified per computed tomography among subjects undergoing TAVI for severe, symptomatic aortic stenosis.

Trial Locations (1)

20132

IRCCS San Raffaele, Milan

All Listed Sponsors
lead

Matteo Montorfano

OTHER